GH Research (GHRS) Cash from Operations (2020 - 2025)

GH Research's (GHRS) quarterly Cash from Operations came in at 12330000.0 in Q4 2025, down 18.04% year-on-year from 15043118.43 in Q4 2024, and up 9.88% quarter-over-quarter from 13682000.0 in Q3 2025.

GH Research (GHRS) Cash from Operations (2020 - 2025) Analysis & Trends

GH Research's Cash from Operations history runs 6 years deep, the most recent figure standing at 12330000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 18.04% year-over-year to 12330000.0 in Q4 2025; TTM through Dec 2025 was 43552000.0, a 3.0% decrease from a year earlier, with the FY2025 full-year figure at 43552000.0, down 3.0% from the prior year.
  • Cash from Operations advanced to 12330000.0 in Q4 2025 per GHRS's latest filing, from 13682000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 1087000.0 in Q1 2021 and bottomed at 13682000.0 in Q3 2025.
  • The 5-year median for Cash from Operations is 8770000.0 (2025), against an average of 8214050.0.
  • Across the five-year window, Cash from Operations slumped 11864.94% in 2021 and increased 12.68% in 2022, its largest moves.
  • Year by year, Cash from Operations stood at 3749000.0 in 2021, then sank by 83.17% to 6867000.0 in 2022, then plunged by 70.67% to 11720000.0 in 2023, then gained by 10.87% to 10446000.0 in 2024, then retreated by 18.04% to 12330000.0 in 2025.
  • Per Business Quant, the three latest GHRS Cash from Operations figures stand at 12330000.0 (Q4 2025), 13682000.0 (Q3 2025), and 8967000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -19.59 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -2.49 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 201.34 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.43 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 1.08 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -354.17 Mn
10 GH Research 1.65 Bn 1.65 Bn - -12.33 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -12.33 Mn
Dec 31, 2025 -12.33 Mn
Sep 30, 2025 -13.68 Mn
Sep 30, 2025 -13.68 Mn
Jun 30, 2025 -8.97 Mn
Jun 30, 2025 -8.97 Mn
Mar 31, 2025 -8.57 Mn
Mar 31, 2025 -8.57 Mn
Dec 31, 2024 -10.45 Mn
Dec 31, 2024 -10.45 Mn
Sep 30, 2024 -12.31 Mn
Sep 30, 2024 -12.31 Mn
Jun 30, 2024 -9.94 Mn
Jun 30, 2024 -9.94 Mn
Mar 31, 2024 -9.60 Mn
Mar 31, 2024 -9.60 Mn
Dec 31, 2023 -11.72 Mn
Dec 31, 2023 -11.72 Mn
Sep 30, 2023 -10.34 Mn
Sep 30, 2023 -10.34 Mn